A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12years

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 7, 2012, Pages 994-1001

  Lue, Ko Haung ^a,b   Sun, Hai Lun ^a,b   Lu, Ko Hsiu ^b   Ku, Min Sho ^a,b   Sheu, Ji Nan ^a,b   Chan, Ching Hui ^a   Wang, Yun Hu ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytokine; Lactobacillus johnsonii EM1; Levocetirizine; Pediatric Rhinoconjunctivitis Quality of Life Questionnaire; Perennial allergic rhinitis; Probiotics; Total symptom score

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; LEVOCETIRIZINE; PROBIOTIC AGENT; RESISTIN; TRANSFORMING GROWTH FACTOR BETA;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTOBACILLUS JOHNSONII; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PEAK EXPIRATORY FLOW; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE;

CETIRIZINE; CHILD; CROSS-OVER STUDIES; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LACTOBACILLUS; PROBIOTICS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84861923452     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2012.03.018     Document Type: Article

References (57)

1. Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). Clin. Exp. Allergy Rev. 2003, 3:43-45.
2. Liao P.F., Sun H.L., Lu K.H., Lue K.H. Prevalence of childhood allergic diseases in central Taiwan over the past 15 years. Pediatr. Neonatol. 2009, 50(1):18-25.
3. Wu W.F., Wan K.S., Wang S.J., Yang W., Liu W.L. Prevalence, severity, and time trends of allergic condition in 6-to-7 year-old school children in Taipei. J. Invest. Allerg. Clin. Immunol. 2011, 21(7):556-562.
4. Meltzer E.O., Nathan R., Derebery J., Stang P.E., Campbell U.B., Yeh W.S., Corrao M., Stanford R. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009, 30(3):244-254.
5. Blaiss M.S. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc. 2010, 31(5):375-380.
6. Wang D.Y., Hanotte F., Ed Vos C., Clement P. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy 2001, 56:339-343.
7. Tillement J.P. A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonists. Allergy 1995, 50:12-16.
8. Gillard M., Van Der Perren C., Moguuilevsky N., Massingham R., Chatelain P. Binding characteristics of cetirizine and levocetirizine to human H91) histamine receptors: contribution of Lys(191) and Thr(194). Mol. Pharmacol. 2002, 61:391-399.
9. Trorii A., Torii S., Fjiwara S., Tanaka H., Inagaki N., Nagai H. Lactobacillus acidophilus strain L-92 reglates the production of Th1 cytokines as well as Th2 cytokines. Allergol. Int. 2005, 56(3):293-301.
10. Von der Weid T., Ibnou-Zekri N., Pfeifer A. Novel probiotics for the management of allergic inflammation. Digest. Liver Dis. 2002, 34(2):S25-S28.
11. Shida K., Takahashi R., Iwadate E., Tamamizawa K., Yasui H., Sato T., Habu S., Hachimura S. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 2002, 32:563-570.
12. Murosaki S., Yamamoto Y., Ito K., Inokuchi T., Kusaka H., Koshikai Y. Heat-killed Lactobaccillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy Clin. Immonol. 1998, 102(1):57-64.
13. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., Nagai H. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol. Int. 2007, 56:293-301.
14. Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin. Immunol. 2009, 5(5):1-7.
15. Peng G.C., Hsu C.H. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennialallergic rhinitis induced by house-dust mite. Pediatr. Allergy Immunol. 2005, 16:433-438.
16. Wang M.F., Lin H.C., Wang Y.Y., Hsu C.H. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr. Allergy Immunol. 2004, 15:152-158.
17. Tamura M., Shikina T., Morihana T., Hayama M., Kajimoto O., Sakamoto A., Kajimoto Y., Watanabe O., Nonaka C., Shida K., Nanno M. Effects of probiotics on allergic rhinitis induced by Japanese Cedar pollen: randomized double-blind, placebo-controlled clinical trial. Int. Arch. Allergy Immunol. 2006, 143:75-82.
18. Ozdemir O. Any benefits of probiotics in allergic disorders?. Allergy Asthma Proc. 2010, 31(2):103-111.
19. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
20. Helin T., Haahtela S., Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled doubleblind study. Allergy 2002, 57:243-246.
21. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Nase L., Saxelin M., Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001, 322:1327-1329.
22. Tamura M., Shikina T., Hayama M., Kajimoto O., Sakamoto A., Kajimoto Y., Watanabe O., Nonaka C., Shida K., Nanno M. Effect of probiotics on allergic rhinitis induced by Japanese ceda pollen: randomized double-blind, placebo-controlled clinical trial. Int. Arch. Allergy Immonol. 2007, 143:75-82.
23. Vliagoftis H., Kouranos V.D., Betsi G.I., Falagas M.E. Probiotics for the treatment of allergic rhinitis and asthma: systemic review of randomized controlled trials. Ann. Allergy Asthma Immunol. 2008, 101:570-579.
24. Vanderhoof J.A., Young R.J. Current and potential uses of probiotics. Ann. Allergy Asthma Immunol. 2004, 93(5 Suppl. 3):S33-S37.
25. Ogden N.S., Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr. Opin. Allergy Clin. Immunol. 2005, 5:179-184.
26. Corren J. Allergic rhinitis and asthma: how important is the link?. J. Allergy Clin. Immunol. 1997, 99(2):S781-S786.
27. Juniper E.F., Howland W.C., Roberts N.B., Thompson A.K., King D.R., Matha B. Measuring quality of life in children with rhinoconjunctivitis. J. Allergy Clin. Immunol. 1998, 101:163-170.
28. Lee C.F., Sun H.L., Lu K.H., Ku M.S., Lue K.H. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Pediatr. Allergy Immunol. 2009, 20:493-499.
29. Potter P.C. Study Group. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 2003, 58:893-899.
30. Murdoch D., Goa K.L., Keam S.J. Desloratadine: an update of its efficacy in the management of allergic disorders. Drugs 2003, 63(19):2051-2077.
31. Bachert C., Bousquet J., Canonica G.W., Durhan S.R., Klimek L., Mullol J., et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J. Allergy Clin. Immunol. 2004, 114:838-844.
32. Bousquet J., Demarteau N., Mullol J., van den Akker-van Marle M.E., Van Ganse E., Bachert C. Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 2005, 60:788-794.
33. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 2003, 37:105-118.
34. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Sci. 1998, 81:48-53.
35. Saito H., Morikawa H., Howie K., Crawford B.L., Baatjes A.J., Denburg E. Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis. Immunology 2004, 113(2):246-252.
36. Strachan D.P. Hay fever hygiene, and household size. BMJ 1989, 299(6710):1259-1260.
37. Isolauri E., Majamaa H., Arvola T., Rantala I., Virtanen E., Arvilommi H. Lactobacillus casei strain GG reverse increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993, 105:1643-1650.
38. Kirjavainen P.V., Apostolou E., Arvola T., Salminen S.J., Gibson G.R., Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. Immunol. Med. Microbiol. 2001, 32:1-7.
39. Wheeler J.G., Bogle M.L., Shema S.J. Impact of dietary yogurt on immune function. Am. J. Med. Sci. 1997, 313:120-123.
40. Hsueh K.C., Lin C.Y., Lin Y.J. Serum levels of resistin in allergic rhinitis and its relationship with disease severity. Am. J. Rhinol. Allergy 2009, 23:365-369.
41. Pochard P., Gosset P., Grangette C., Andre C., Tonnel A.B., Pestel J., Mercenier A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immunol. 2002, 110:617-623.
42. Prescott S.L., Dunstan J.A., Hale J., Breckler L., Lehmann H., Weston S., Richmond P. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin. Exp. Allergy 2005, 35:1557-1564.
43. Matszaki T., Chin J. Modulating immune responses with probiotic bacteria. Immunol. Cell Biol. 2000, 78:67-73.
44. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., Zaat B.A., Yazdanbakhsh M., Wierenga E.A., van Kooyk Y., Kapsenberg M.L. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115:1260-1267.
45. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., Bavari S., Klaenhammer T.R. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2880-2885.
46. Tournoy K.G., Kips J.C., Pauwels R.A. Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin. Exp. Allergy 2000, 30:775-783.
47. Pessi T., Sutas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 2000, 30:1804-1808.
48. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 2005, 174:3237-3246.
49. Lammers K.M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., Matteuzzi D., Campieri M. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 2003, 38:165-172.
50. Chen S.Y., Jan R.L., Lin Y.L., Chen H.H., Wang J.Y. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr. Pulmonol. 2010, 45(11):1111-1120.
51. Weiner H.L. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001, 3:947-954.
52. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
53. Thoma-Uszynski S., Kiertscher S.M. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 2000, 165:3804-3810.
54. Sieling P.A., Chung W., Duong B.T., Godowski P.J., Modlin R.L. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J. Immunol. 2003, 170:194-200.
55. Pelto L., Isolaurie E., Lilius E.M., Nuutila J., Salminen S. Probiotic bacteria down regulate the milk induced inflammatory response in milk hypertensive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 1998, 28:1474-1479.
56. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., Savilahti E. Lactobacillus G. effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 2004, 114:131-136.
57. Nogueira J.C.R., Concalves M.C.R. Probiotics in allergic rhinitis. Braz. J. Otorhinolaryngol. 2011, 77(1):129-134.